TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 18.49%186.91M | -16.81%294.47M | -17.81%157.74M | 15.65%353.95M | 34.26%191.91M | -11.13%306.05M | -29.59%142.94M | -38.35%344.39M | -36.51%203.01M | 7.18%558.6M |
Operating income | 18.49%186.91M | -16.81%294.47M | -17.81%157.74M | 15.65%353.95M | 34.26%191.91M | -11.13%306.05M | -29.59%142.94M | -38.35%344.39M | -36.51%203.01M | 7.18%558.6M |
Cost of sales | -15.70%-168.46M | 14.28%-273.08M | 12.94%-145.6M | -14.12%-318.58M | -35.86%-167.23M | 4.27%-279.15M | 29.02%-123.09M | 40.82%-291.6M | 37.62%-173.42M | -11.53%-492.74M |
Operating expenses | -15.70%-168.46M | 14.28%-273.08M | 12.94%-145.6M | -14.12%-318.58M | -35.86%-167.23M | 4.27%-279.15M | 29.02%-123.09M | 40.82%-291.6M | 37.62%-173.42M | -11.53%-492.74M |
Gross profit | 51.94%18.45M | -39.51%21.39M | -50.81%12.14M | 31.47%35.37M | 24.33%24.68M | -49.05%26.9M | -32.91%19.85M | -19.84%52.8M | -29.08%29.59M | -17.04%65.86M |
Selling expenses | -21.91%-7.85M | 34.47%-14.45M | 54.55%-6.44M | 29.17%-22.05M | 3.61%-14.17M | -46.52%-31.13M | -26.60%-14.7M | -9.37%-21.25M | -105.02%-11.61M | -69.97%-19.43M |
Administrative expenses | -19.73%-19.32M | 25.62%-32.56M | 42.89%-16.13M | 45.17%-43.78M | -22.24%-28.25M | -99.43%-79.84M | -26.23%-23.11M | 18.59%-40.03M | 25.88%-18.31M | -7.70%-49.18M |
Revaluation surplus | ---- | ---- | ---- | ---- | ---- | -1,403.98%-7.54M | ---- | 107.71%578K | ---- | ---7.5M |
-Changes in the fair value of other assets | ---- | ---- | ---- | ---- | ---- | -1,403.98%-7.54M | ---- | 107.71%578K | ---- | ---7.5M |
Impairment and provision | ---- | -642.34%-68.7M | ---- | 47.74%-9.25M | ---- | 17.49%-17.71M | ---- | -18,892.92%-21.46M | ---- | 82.64%-113K |
-Impairment of intangible assets | ---- | ---- | ---- | ---- | ---- | ---1.45M | ---- | ---- | ---- | ---- |
-Impairment of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | 69.85%-5.04M | ---- | ---16.7M | ---- | ---- |
-Goodwill impairment | ---- | ---- | ---- | ---- | ---- | ---5.67M | ---- | ---- | ---- | ---- |
-Other impairment is provision | ---- | -642.34%-68.7M | ---- | -66.77%-9.25M | ---- | -16.62%-5.55M | ---- | -4,110.62%-4.76M | ---- | 82.64%-113K |
Special items of operating profit | -132.39%-1.37M | -75.53%4.66M | -50.50%4.22M | 258.51%19.03M | 218.82%8.53M | -1,067.98%-12M | -411.72%-7.18M | -87.65%1.24M | 67.93%2.3M | -28.87%10.04M |
Operating profit | -62.50%-10.09M | -333.41%-89.66M | 32.53%-6.21M | 82.95%-20.69M | 63.39%-9.2M | -331.26%-121.32M | -1,372.91%-25.14M | -8,945.66%-28.13M | -84.49%1.98M | -100.87%-311K |
Financing cost | -37.26%-1.89M | 22.99%-3.05M | 41.28%-1.37M | -2.41%-3.95M | 2.82%-2.34M | -4.61%-3.86M | 32.21%-2.41M | 66.84%-3.69M | 35.57%-3.55M | -5.89%-11.13M |
Earning before tax | -57.92%-11.98M | -276.22%-92.71M | 34.30%-7.58M | 80.32%-24.64M | 58.09%-11.54M | -293.37%-125.18M | -1,646.86%-27.55M | -178.15%-31.82M | -121.85%-1.58M | -145.29%-11.44M |
Tax | -102.96%-8K | 99.04%-46K | 110.44%270K | -88.14%-4.79M | -119.80%-2.59M | -2.33%-2.55M | 53.05%-1.18M | 48.21%-2.49M | 40.21%-2.51M | 26.74%-4.81M |
After-tax profit from continuing operations | -63.86%-11.99M | -215.13%-92.75M | 48.24%-7.31M | 76.96%-29.43M | 50.81%-14.13M | -272.26%-127.73M | -603.35%-28.73M | -111.19%-34.31M | -235.05%-4.08M | -186.88%-16.25M |
Earning after tax | -63.86%-11.99M | -215.13%-92.75M | 48.24%-7.31M | 76.96%-29.43M | 50.81%-14.13M | -272.26%-127.73M | -603.35%-28.73M | -111.19%-34.31M | -235.05%-4.08M | -186.88%-16.25M |
Profit attributable to shareholders | -63.86%-11.99M | -215.13%-92.75M | 48.24%-7.31M | 76.96%-29.43M | 50.81%-14.13M | -272.26%-127.73M | -603.35%-28.73M | -111.19%-34.31M | -235.05%-4.08M | -186.88%-16.25M |
Basic earnings per share | -64.41%-0.0291 | -180.30%-0.2248 | 59.95%-0.0177 | 81.24%-0.0802 | 54.67%-0.0442 | -140.49%-0.4276 | -351.39%-0.0975 | -107.23%-0.1778 | -313.86%-0.0216 | -1,851.02%-0.0858 |
Diluted earnings per share | -64.41%-0.0291 | -180.30%-0.2248 | 59.95%-0.0177 | 81.24%-0.0802 | 54.67%-0.0442 | -140.49%-0.4276 | -351.39%-0.0975 | -107.23%-0.1778 | -313.86%-0.0216 | -1,851.02%-0.0858 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | Kaiyuan Shun Tak Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.